The results demonstrated that the expression of Chk2 and phospho-Chk2 was downregulated in DUSP6-overexpressing ESCC cells (KYSE450 and KYSE510), which promoted the expression of cyclinB1 and phospho-cdc2. This evidence concerns the gene CDK1 and esophageal squamous cell carcinoma.